Peripheral Vascular Devices Market Analysis, Size, Trends | United States | 2020-2026 | MedSuite

Peripheral Vascular Devices Market Analysis, Size, Trends | United States | 2020-2026 | MedSuite

0

  • Year: 2020
  • Scope: 2016-2026
  • Region: United States
  • Published Date: 01/10/2020
  • Pages: 998
  • Type: MedSuite

Throughout this medical market research, we analyzed 67 peripheral vascular companies across the United States and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.

While this MedSuite report contains all the US Peripheral Vascular market data and analysis, each of the market segments are also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.

Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Forecasts Until 2026, and Historical Data to 2016
  • Market Drivers & Limiters for Each Peripheral Vascular Device market
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Peripheral Vascular Procedure Volumes
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors
  • Related Press Releases from Top Competitors

Market Value and Industry Trends

The U.S. Peripheral Vascular device market was valued at $7.1 billion by 2020. This value is expected to increase and reach $10.4 billion by 2026. There are over 8.26 million peripheral vascular procedures performed each year.

Across the market, there is growing availability to treat chronic limb ischemia, in the small vasculature in the legs. Lower-profile devices are being developed, and technologies to reduce restenosis are increasingly being used. In conjunction with this trend, there is also a trend amongst physicians to aim to leave fewer permanent devices within a patient, opting instead for atherectomy products. For this reason, the atherectomy market continues to grow, and there are multiple factors contributing to the market’s expansion.

US Peripheral Vascular Market Value

One of the greatest limitations in this market is the pricing pressure that is occurring within the office-based lab (OBL) setting. Although these clinics have led to a significant increase in efficiency, reducing the average time for patients to be within a hospital, these settings are also incredibly price-sensitive. It is typical that there is a 30% discount on devices sold to an OBL, relative to a hospital.

After the publication of a meta-analysis by Konstantinos Katsanosin in December 2018, the markets for drug-coated balloons (DCB) and drug-eluting stents (DES) experienced a great negative shock and are on a path to recovery. At the start of 2019, the FDA announced that they would re-examine the safety of paclitaxel products. Shortly after, a large movement occurred away from paclitaxel and towards more traditional devices. Although the FDA released a statement in August 2019 stating that they were not able to identify a late-mortality signal caused by paclitaxel use in the peripheries, hesitancy about the use of these devices remains.

Competitive Analysis

Peripheral Vascular Market LeadersMedtronic was the leading competitor in the US peripheral vascular devices market in 2019. The company derived its leading position from a strong showing in the high-value stent graft, DCB, and atherectomy market segments.

W.L. Gore is the second leading competitor in the peripheral vascular market. The company acquired this position through its strong presence in the stent and stent-graft markets.

The third leading competitor in the US market is Boston Scientific. After its successful acquisition of  BTG plc., the company was able to become a key provider in the peripheral thrombus management and transcatheter embolization device markets.

Detailed Market Segmentation

  • Peripheral Vascular Stent Market MedCore – The analysis provides insight into the Bare-Metal, Covered, and Drug-Eluting Stent Markets.
  • Venous Stent Market – MedCore – An in-depth analysis of the Venous Stent Market.
  • PTA Balloon Catheter Market – MedCore – The market is segmented into Standard, High-Pressure, Large, Small, and Specialty PTA Balloon Catheters.
  • Drug-Coated Balloon Market – MedCore – The market is further segmented by Sheath Sizes, Balloon diameters, and Balloon lengths, Device indication, Rated Burst Pressure, and by Care Setting.
  • Atherectomy Device Market – MedCore – This market consists of two major segments: Laser Atherectomy and Mechanical Atherectomy Devices.
  • Intravascular Lithotripsy Market – MedCore – The analysis covers Intravascular lithotripsy (IVL), which is a newer procedure for the peripheral cardiovascular space.
  • Chronic Total Occlusion Device Market – MedCore – The market is further segmented into Re-Entry Chronic Total Occlusion Device and Re-Canalization Chronic Total Occlusion Device Markets.
  • Surgical Graft Market – MedCore – This market is segmented into Lower Limb Surgical Grafts (Above-the-Knee, Below-the-Knee), Aorta Repair Surgical Grafts (Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm) and Extra-Anatomical Bypass Surgical Grafts.
  • Stent Graft Market – MedCore – Segmented by AAA Stent Grafts (Bifurcated, Contralateral/Ipsilateral Iliac Leg/Limb, AUI, Iliac Extension, Aortic Extension), Fenestrated Stent Grafts, and TAA Stent Grafts.
  • Embolic Protection Device Market – MedCore – Segmented further into Carotid Embolic Protection and Alternative Embolic Protection Devices.
  • Peripheral Thrombus Management Device Market – MedCore – Market analysis is segmented by Device Type and Indication.
  • Inferior Vena Cava Filter & Retrieval Device Market – MedCore – This market includes segmentation on both Retrievable and Permanent Inferior Vena Cava Filters, as well as Filter Retrieval Devices.
  • Carotid Shunt Market – MedCore – A carotid shunt is a piece of medical tubing used by some physicians in carotid endarterectomy procedures.
  • Transcarotid Artery Revascularization MarketMedCore – Transcarotid artery revascularization (TCAR) is a development of transcarotid therapies for intra- and extracranial vascular diseases.
  • Diagnostic & Interventional Catheter Market – MedCore – This market is comprised of diagnostic and support catheters. Diagnostic catheters are used in combination with X-ray imaging to visualize the main arteries in the body.
  • Diagnostic & Interventional Guidewire Market – MedCore – Covers two main markets, Standard Guidewires and Hydrophilic Guidewires.
  • Introducer Sheath Market – MedCore – Further segmented into Standard and Guiding Introducer Sheaths.
  • Vascular Closure Device Market – MedCore – This market includes segmentation by Device Type (Invasive, Non-Invasive) and Approach (Femoral, Radial).
  • Transcatheter Embolization Device Market – MedCore – Covers four main markets: Embolization Particles (PVA, Microsphere, Drug-Eluting, Radioactive), Embolization Coils (Pushable, Detachable), Embolization Liquids, and Embolization Plugs.
  • Peripheral IVUS Catheter Market – MedCore  – An IVUS system consists of two components: the disposable IVUS catheter and the IVUS consoles.
  • Procedure numbers for the US Peripheral Vascular marketMedProThe in-depth analysis of Peripheral Vascular procedures performed in the United States, based on CPT codes.

DON’T SEE THE SEGMENT OR DATA YOU NEED?

Feel free to contact us or send a request by pressing one of the buttons below.

For a Full Table of Contents, please contact iData.

Table of Contents for US Peripheral Vascular Report Suite

TABLE OF CONTENTS I
LIST OF FIGURES XXIII
LIST OF CHARTS XLIII
EXECUTIVE SUMMARY 1
U.S. PERIPHERAL VASCULAR DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 9
MARKET DEVELOPMENTS 12
PROCEDURE NUMBERS 13
PROCEDURE CODES INVESTIGATED 21
MARKETS INCLUDED 22
KEY REPORT UPDATES 30
VERSION HISTORY 31
RESEARCH METHODOLOGY 32
1.1.1 Step 1: Project Initiation & Team Selection 32
1.1.2 Step 2: Prepare Data Systems and Perform Secondary Research 35
1.1.3 Step 3: Preparation for Interviews & Questionnaire Design 36
1.1.4 Step 4: Performing Primary Research 37
1.1.5 Step 5: Research Analysis: Establishing Baseline Estimates 39
1.1.6 Step 6: Market Forecast and Analysis 40
1.1.7 Step 7: Identify Strategic Opportunities 42
1.1.8 Step 8: Final Review and Market Release 43
1.1.9 Step 9: Customer Feedback and Market Monitoring 44

DISEASE OVERVIEW 45

2.1 BASIC ANATOMY 45
2.2 DISEASE TREATMENTS & DIAGNOSTICS 46
2.2.1 Aortic Aneurysms 46
2.2.2 Atherosclerosis 47
2.2.3 Peripheral Arterial Disease (PAD) 48
2.2.4 Deep Vein Thrombosis (DVT) 49
2.2.5 Pulmonary Embolism (PE) 50
2.3 PATIENT DEMOGRAPHICS 52
2.3.1 Aortic Aneurysms 52
2.3.2 Atherosclerosis 52
2.3.3 Peripheral Arterial Disease (PAD) 52
2.3.4 Deep Vein Thrombosis (DVT) 53
2.3.5 Pulmonary Embolism (PE) 53

PRODUCT ASSESSMENT 55

3.1 INTRODUCTION 55
3.2 PRODUCT PORTFOLIOS 55
3.2.1 Peripheral Vascular Stent 55
3.2.2 Venous Stent 58
3.2.3 Percutaneous Transluminal Angioplasty (PTA) Balloon 59
3.2.4 Drug-Coated Balloon 63
3.2.5 Atherectomy Device 65
3.2.6 Chronic Total Occlusion (CTO) Device 67
3.2.7 Intravascular Lithotripsy 69
3.2.8 Surgical Graft 70
3.2.9 Stent Graft 73
3.2.10 Embolic Protection Device 75
3.2.11 Peripheral Thrombus Management Device 77
3.2.12 Inferior Vena Cava Filter 80
3.2.13 Carotid Shunt 81
3.2.14 Diagnostic and Interventional Catheters 82
3.2.15 Diagnostic and Interventional Guidewire 85
3.2.16 Introducer Sheath 89
3.2.17 Vascular Closure Device (VCD) 93
3.2.18 Transcatheter Embolization Device 95
3.2.19 Peripheral IVUS Catheter 98
3.3 REGULATORY ISSUES AND RECALLS 99
3.3.1 Abbott 99
3.3.1.1 Carotid Shunt 99
3.3.1.2 Vascular Closure Device 99
3.3.2 Argon Medical 100
3.3.2.1 Introducer Sheaths 100
3.3.3 Arrow International 101
3.3.3.1 Introducer Sheaths 101
3.3.4 Atrium Medical 103
3.3.4.1 Peripheral Vascular Stent 103
3.3.5 BD 104
3.3.5.1 Inferior Vena Cava Filter 104
3.3.5.2 Introducer Sheaths 104
3.3.5.3 Stent Graft 105
3.3.6 Boston Scientific 106
3.3.6.1 Atherectomy Devices 106
3.3.6.2 Diagnostic and Interventional Catheters 107
3.3.6.3 Introducer Sheaths 108
3.3.6.4 Peripheral Thrombus Management Devices 109
3.3.7 Cardinal Health 110
3.3.7.1 Vascular Closure Devices 110
3.3.8 Cardiovascular System (C.S.I.) 111
3.3.8.1 Atherectomy Devices 111
3.3.9 Cook Medical 113
3.3.9.1 Diagnostic and Interventional Catheters 113
3.3.9.2 Introducer Sheaths 113
3.3.9.3 Inferior Vena Cava Filters 114
3.3.9.4 Peripheral Vascular Stents 115
3.3.9.5 Stent Grafts 115
3.3.10 Cordis (Cardinal Health) 116
3.3.10.1 Diagnostic and Interventional Catheters 116
3.3.10.2 Inferior Vena Cava Filters 116
3.3.10.3 Peripheral Stents 117
3.3.11 Endologix 118
3.3.11.1 Stent Grafts 118
3.3.12 Edwards Lifesciences 120
3.3.12.1 Chronic Total Occlusion Devices 120
3.3.13 Maquet 121
3.3.13.1 PTA Balloons 121
3.3.14 Medtronic 122
3.3.14.1 Carotid Shunts 122
3.3.14.2 Diagnostic and Interventional Catheters 122
3.3.14.3 PTA Balloon Catheters 123
3.3.14.4 Peripheral Stents 124
3.3.14.5 Stent Grafts 124
3.3.14.6 Transcatheter Embolization Devices 125
3.3.15 Spectranetics (Philips) 126
3.3.15.1 Atherectomy Devices 126
3.3.15.2 Chronic Total Occlusion Devices 127
3.3.16 Shockwave Medical, Inc. 128
3.3.16.1 Intravascular Lithotripsy 128
3.3.17 Terumo 129
3.3.17.1 Introducer Sheaths 129
3.3.17.2 PTA Balloon Catheters 129
3.3.18 Other Companies 130
3.3.18.1 Atherectomy Devices 130
3.3.18.2 Introducer Sheaths 130
3.3.18.3 PTA Balloon Catheters 130
3.3.18.4 Peripheral IVUS Catheters 131
3.3.18.5 Stent Grafts 131
3.3.18.6 Vascular Closure Devices (VCD) 132
3.4 CLINICAL TRIALS 133
3.4.1 Abbott 133
3.4.1.1 Peripheral Vascular Stent 133
3.4.1.2 Other Peripheral Vascular Related Studies 136
3.4.2 B. Braun 137
3.4.2.1 Diagnostic and Interventional Catheters 137
3.4.2.2 Peripheral Vascular Stent 137
3.4.3 Boston Scientific 138
3.4.3.1 Atherectomy Devices 138
3.4.3.2 Drug-Coated Balloons 139
3.4.3.3 Peripheral Vascular Stents 141
3.4.3.4 Other Peripheral Vascular Related Studies 142
3.4.3.5 Venous Stents 142
3.4.4 C.R. Bard (BD) 143
3.4.4.1 Diagnostic and Interventional Catheters 143
3.4.4.2 Drug-Coated Balloons 143
3.4.4.3 Venous Stents 145
3.4.4.4 Other Peripheral Vascular Related Studies 146
3.4.5 Cardinal Health 147
3.4.5.1 Other Peripheral Vascular Related Studies 147
3.4.6 Cook Medical 148
3.4.6.1 Drug-Eluting Stents 148
3.4.6.2 Inferior Vena Cava Filters 150
3.4.6.3 Peripheral Vascular Stents 150
3.4.6.4 Venous Stents 151
3.4.7 Cordis (Cardinal Health) 152
3.4.7.1 Peripheral Vascular Stents 152
3.4.8 Medtronic 153
3.4.8.1 Atherectomy Devices 153
3.4.8.2 Drug-Coated Balloons 154
3.4.8.3 Other Peripheral Vascular Related Studies 160
3.4.9 Merit Medical 162
3.4.9.1 Stent Grafts 162
3.4.10 Philips/Spectranetics 163
3.4.10.1 Atherectomy Devices 163
3.4.10.2 Peripheral IVUS Catheters 163
3.4.10.3 Spectranetics 164
3.4.10.3.1 Drug-Coated Balloons 164
3.4.10.3.2 Atherectomy Devices 167
3.4.11 Shockwave Medical, Inc. 168
3.4.11.1 Lithoplasty System 168
3.4.12 Surmodics 169
3.4.12.1 Drug-Coated Balloons 169
3.4.13 Terumo 170
3.4.13.1 Drug-Coated Balloons 170
3.4.13.2 Peripheral Vascular Stents 170
3.4.14 W.L. Gore 171
3.4.14.1 Peripheral Vascular Stents 171
3.4.14.2 Stent Grafts 172
3.4.14.3 Expandable Balloons 173
3.4.15 Other Companies 174
3.4.15.1 Carotid Shunt / Endarterectomy 174
3.4.15.2 Drug-Coated Balloons 175
3.4.15.3 Peripheral Vascular Stents 179
3.4.15.4 Other Peripheral Vascular Related Studies 182

U.S. PERIPHERAL VASCULAR DEVICE MARKET OVERVIEW 183

4.1 INTRODUCTION 183
4.1.1 Atherosclerosis 183
4.1.2 Peripheral Arterial Disease (PAD) 184
4.2 MARKET OVERVIEW 185
4.3 TREND ANALYSIS BY SEGMENT 192
4.4 DRIVERS AND LIMITERS 197
4.4.1 Market Drivers 197
4.4.2 Market Limiters 201
4.5 COMPETITIVE MARKET SHARE ANALYSIS 205
4.6 MERGERS AND ACQUISITIONS 218
4.7 COMPANY PROFILES 222
4.7.1 Abbott 222
4.7.2 Becton Dickinson (BD) 223
4.7.3 Boston Scientific 224
4.7.4 Cardinal Health 225
4.7.4.1 Cordis (Cardinal Health) 225
4.7.5 Cook Medical 226
4.7.6 Maquet 227
4.7.7 Medtronic 228
4.7.8 Teleflex 230
4.7.9 Terumo Interventional System (TIS) 231
4.7.10 W.L. Gore 232
4.8 SWOT ANALYSIS 233
4.8.1 Abbott 234
4.8.2 B. Braun 235
4.8.3 Boston Scientific 236
4.8.4 BD 237
4.8.5 Cardinal Health 238
4.8.6 Cook Medical 239
4.8.7 Integra Lifesciences 240
4.8.8 Maquet 241
4.8.9 Medtronic 242
4.8.10 Merit Medical 243
4.8.11 Phillips 244
4.8.12 Teleflex 245
4.8.13 Terumo 246
4.8.14 W.L. Gore 247

PROCEDURE NUMBERS 248

5.1 INTRODUCTION 248
5.2 PROCEDURES 249
5.2.1 Total Peripheral Vascular Procedures 249
5.2.2 Total Peripheral Vascular Procedures by Device Type, Indication, Intervention & Care Setting 256
5.2.2.1 Above-the-Knee Procedures 257
5.2.2.1.1 Above-the-Knee Stent Procedures 259
5.2.2.1.2 Above-the-Knee POBA Procedures by Care Setting 261
5.2.2.1.3 Above-the-Knee DCB Procedures by Care Setting 262
5.2.2.1.4 Above-the-Knee Atherectomy without Stent Procedures by Care Setting 263
5.2.2.1.5 Above-the-Knee Atherectomy with Stent Procedures by Care Setting 264
5.2.2.2 Below-the-Knee Procedures 265
5.2.2.2.1 Below-the-Knee Stent Procedures by Device Type 267
5.2.2.2.2 Below-the-Knee Stent Procedures by Care Setting 268
5.2.2.2.3 Below-the-Knee POBA Procedures by Care Setting 269
5.2.2.2.4 Below-the-Knee DCB Procedures by Care Setting 270
5.2.2.2.5 Below-the-Knee Atherectomy without Stent Procedures by Care Setting 271
5.2.2.2.6 Below-the-Knee Atherectomy with Stent Procedures by Care Setting 272
5.2.2.3 Iliac Procedures 273
5.2.2.3.1 Iliac Stent Procedures by Device Type 274
5.2.2.3.2 Iliac Stent Procedures by Care Setting 275
5.2.2.3.3 Iliac POBA Procedures by Care Setting 276
5.2.2.4 AV Access Procedures 277
5.2.2.4.1 AV Access Covered Stent Procedures by Care Setting 278
5.2.2.4.2 AV Access POBA Procedures by Care Setting 279
5.2.2.4.3 AV Access DCB Procedures by Care Setting 280
5.2.2.5 Renal Procedures 281
5.2.2.6 Carotid Procedures 282
5.2.3 Peripheral Vascular Stent Procedures 283
5.2.3.1 Peripheral Arterial Stent Procedures by Stent Type 286
5.2.3.1.1 Bare-Metal Stent Procedures 288
5.2.3.1.2 Covered Stent Procedures 293
5.2.3.1.3 Drug-Eluting Stent Procedures 295
5.2.4 Peripheral Venous Stent 297
5.2.5 PTA Balloon Catheter Procedures 300
5.2.6 Drug-Coated Balloon Procedures 303
5.2.6.1 Drug-Coated Balloon Procedures by Indication 305
5.2.7 Atherectomy Procedures 309
5.2.7.1 Atherectomy Procedures by Device Type 311
The Peripheral Vascular Devices Market Report Suite| United States | 2020-2026 | MedSuite includes analysis on the following companies currently active in this market:

  • Abbott Vascular
  • Acist Medical
  • Advanced Vascular Dynamics
  • AngioDynamics
  • Argon Medical
  • ArtVentive
  • Asahi Intecc USA Inc.
  • AV Medical
  • Avinger
  • B. Braun
  • Baylis Medical
  • Biotronik
  • Blockade Medical
  • Boston Scientific
  • C.R. Bard
  • Cardinal Health
  • Cardiovascular Systems Inc.
  • Maquet
  • Medline
  • Medtronic
  • Merit Medical
  • Mermaid Medical
  • Micro Medical Solutions
  • Morris Innovative Inc.
  • Nipro
  • NuCryo Vascular
  • Oscor
  • Penumbra
  • Pfizer
  • PFM Medical
  • Philips
  • Provisio Medical
  • Ra Medical
  • Radius Medical
  • Cardiva
  • Cerenovus
  • CME
  • Concordance Healthcare
  • Consolidated Service Center
  • Control Medical Technology
  • Cook Medical
  • Creagh Medical
  • Direct Access Medical
  • Edwards LifeSciences
  • Endologix
  • Galt Medical
  • Inari Medical
  • Infraredx
  • Integra LifeSciences
  • LeMaitre Vascular
  • Lucas Medical
  • Reflow Medical
  • Rex Medical
  • Roxwood Medical
  • Shockwave Medical
  • Silk Road Medical
  • Sirtex
  • Surmodics
  • Teleflex Medical
  • Terumo
  • Theragenics/Galt
  • Tricol Biomedical
  • TriReme Medical
  • TZ Medical
  • Varian Medical Systems
  • Vascular Flow Technologies
  • W. L. Gore

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology


close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link
close-link